Please check your internet connection and try again.
## Sodium Phosphate Enema
### Overview
Sodium phosphate enema is a hypertonic saline solution used as a laxative for bowel cleansing prior to diagnostic procedures or surgical procedures, and for the treatment of occasional constipation.
### Primary Indications
* Bowel preparation for colonoscopy or surgery.
* Relief of occasional constipation.
### Adult Dosing
* **Bowel Preparation:** Typically, one 4.5 oz (133 mL) enema administered as a single dose, 12-24 hours before the procedure. Some protocols may involve a second dose. Follow specific institutional or procedural guidelines.
* **Constipation:** One 4.5 oz (133 mL) enema administered as a single dose, usually within 5 minutes. May repeat in 24 hours if needed. Do not use for more than 7 consecutive days without consulting a healthcare provider.
### Pediatric Dosing
* **Children 2-12 years:** One 2.25 oz (67 mL) enema.
* **Children under 2 years:** Not recommended due to increased risk of severe adverse events, including hypernatremia, dehydration, and cardiac arrest. Use with extreme caution and under strict medical supervision if deemed absolutely necessary, with doses determined by a healthcare provider.
### Dose Adjustments
* No specific dose adjustments are typically required for renal or hepatic impairment, but caution is advised due to the risk of electrolyte disturbances. Patients with impaired renal function are at higher risk.
### Contraindications
* Congenital or acquired megacolon.
* Intestinal obstruction or perforation.
* Severe renal impairment (CrCl < 30 mL/min).
* Congestive heart failure.
* Acute liver failure.
* Anuria.
* Children under 2 years of age.
* Patients with existing electrolyte abnormalities (e.g., hyperphosphatemia, hypocalcemia).
* Concurrent use of other sodium-containing medications or laxatives.
* Known hypersensitivity to sodium phosphate.
### Adverse Effects
* **Common:** Abdominal cramping, bloating, nausea, vomiting, diarrhea.
* **Serious:**
* **Electrolyte disturbances:** Hyperphosphatemia, hypocalcemia, hypernatremia, hypokalemia. Symptoms may include muscle cramps, tetany, paresthesias, confusion, seizures, cardiac arrhythmias.
* **Dehydration:** Especially in children and elderly patients.
* **Renal impairment/failure:** Particularly in patients with pre-existing renal disease or those who receive repeated doses.
* **Colitis:** Ischemic colitis has been reported.
* **Hypersensitivity reactions:** Rash, urticaria, angioedema.
### Key Drug Interactions
* **Other sodium-containing medications or laxatives:** Increased risk of hypernatremia and fluid overload.
* **Diuretics:** Increased risk of electrolyte imbalances.
* **ACE inhibitors and ARBs:** May increase the risk of hyperkalemia.
* **Calcium or magnesium-containing antacids:** May precipitate and form phosphate stones, leading to kidney stones.
### Monitoring
* **Electrolytes:** Serum electrolytes (sodium, potassium, phosphate, calcium) should be monitored, especially in patients with risk factors for electrolyte disturbances (e.g., renal impairment, elderly, children, repeated doses).
* **Renal function:** Monitor serum creatinine and BUN, especially in patients with risk factors.
* **Hydration status:** Assess for signs of dehydration.
* **Cardiac function:** Monitor for arrhythmias, especially in patients with pre-existing cardiac conditions or electrolyte imbalances.
### Clinical Pearls
* Sodium phosphate enemas are highly effective for bowel cleansing but carry a significant risk of severe electrolyte abnormalities and renal injury, particularly in vulnerable populations.
* Ensure adequate hydration before and after administration.
* Avoid concurrent use with other sodium-containing products.
* Strict adherence to recommended doses and frequency is crucial.
* Use with caution in patients with any degree of renal impairment, elderly patients, very young children, and those with cardiac or gastrointestinal issues.
* Alternative bowel preparation agents should be considered for patients at high risk.
***
*This information is intended for healthcare professionals and should not replace consultation with current prescribing information and local institutional protocols. Always verify the most up-to-date drug information before administration.*
